Paper1804005
In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises.
Thomson KS and 2 others. Antimicrob Agents Chemother, 1991. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises. Papers, record 1804005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1804005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Infective Agents | Major topic |
| Bacteria | Major topic |
| Ciprofloxacin | |
| Drug Resistance, Microbial | |
| Enterobacteriaceae | |
| Microbial Sensitivity Tests | |
| Mutation | |
| Pseudomonas aeruginosa | |
| Staphylococcus |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1649574 | Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1649574 | PubMed |
| 2 | 1649573 | Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1649573 | PubMed |
| 3 | 1827242 | Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1827242 | PubMed |
| 4 | 2024969 | Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/2024969 | PubMed |
| 5 | 2024958 | Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/2024958 | PubMed |
| 6 | 2175305 | The clinical problems of bacterial resistance to the new quinolones. | J Antimicrob Chemother | 1990 | https://conductscience.org/library/papers/2175305 | PubMed |
| 7 | 2889094 | Quinolone/ureidopenicillin cross-resistance. | Lancet | 1987 | https://conductscience.org/library/papers/2889094 | PubMed |
| 8 | 2254224 | Epidemiology of ciprofloxacin resistance among patients with methicillin-resistant Staphylococcus aureus. | J Antimicrob Chemother | 1990 | https://conductscience.org/library/papers/2254224 | PubMed |
| 9 | 2690616 | Bacterial resistance to the quinolone antimicrobial agents. | Am J Med | 1989 | https://conductscience.org/library/papers/2690616 | PubMed |
| 10 | 2680058 | Fluoroquinolone antimicrobial agents. | Clin Microbiol Rev | 1989 | https://conductscience.org/library/papers/2680058 | PubMed |
| 11 | 2679373 | Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2679373 | PubMed |
| 12 | 2663809 | Mechanisms of resistance to quinolones and clinical perspectives. | J Antimicrob Chemother | 1989 | https://conductscience.org/library/papers/2663809 | PubMed |
| 13 | 2086223 | First clinical isolate of highly fluoroquinolone-resistant Escherichia coli in Scandanavia. | Eur J Clin Microbiol Infect Dis | 1990 | https://conductscience.org/library/papers/2086223 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30977288 | lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa. | Microbiologyopen | 2019 | https://conductscience.org/library/papers/30977288 | PubMed |
| 17517839 | Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17517839 | PubMed |
| 16251325 | AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pump. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/16251325 | PubMed |
| 12545697 | The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis. | Trans Am Ophthalmol Soc | 2002 | https://conductscience.org/library/papers/12545697 | PubMed |
| 10378126 | Use of newer quinolones for the treatment of intraabdominal infections: focus on clinafloxacin. | Infection | 1999 | https://conductscience.org/library/papers/10378126 | PubMed |
| 9835538 | Examination of methicillin-resistant and methicillin-susceptible Staphylococcus aureus mutants with low-level fluoroquinolone resistance. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9835538 | PubMed |
| 9257770 | In vitro activity of Bay 12-8039, a new 8-methoxyquinolone. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9257770 | PubMed |
| 9098667 | Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections. | Drugs | 1997 | https://conductscience.org/library/papers/9098667 | PubMed |
| 8285618 | In vitro activity of Bay y 3118, a new quinolone. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8285618 | PubMed |
| 8118787 | Update on clinical significance of coagulase-negative staphylococci. | Clin Microbiol Rev | 1994 | https://conductscience.org/library/papers/8118787 | PubMed |
| 7840550 | Antimicrobial susceptibility of coagulase-negative staphylococci. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7840550 | PubMed |
| 7811025 | Dissociated resistance among fluoroquinolones. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7811025 | PubMed |
| 7492087 | Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7492087 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1804005
GET https://conductscience.org/api/papers/v1/1804005/authors